alendronate

(redirected from alendronate sodium)
Also found in: Dictionary, Medical, Wikipedia.
Related to alendronate sodium: Risedronate sodium
  • noun

Synonyms for alendronate

a tablet (trade name Fosamax) prescribed to prevent or treat osteoporosis in women after menopause

References in periodicals archive ?
By various mechanisms of action, alendronate sodium can enhance bone strength, alleviate and prevent osteoporosis, effectively reduce the risk of fracture in centrum, hip bone and other parts.
Alendronate sodium tablets are indicated for the treatment and prevention of osteoporosis in post menopausal women, to increase bone mass in men with osteoporosis, in the treatment of glucocorticoid induced osteoporosis, and Paget's disease of the bone in men and women.
For example, one of the products that Mission recently introduced to the LTC market is BINOSTO*, a prescription product that is an effervescent alendronate sodium oral solution for the treatment of osteoporosis in post menopausal women and treatment to increase bone mass in men with osteoporosis.
Merrion Pharmaceuticals Ltd, an international specialty pharmaceutical company, today announced the successful completion of a clinical pharmacology study of MER 103, a novel oral formulation of alendronate sodium.
EX101 is a proprietary buffered effervescent dosage form of alendronate sodium administered once weekly for treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis.
Tenders are invited for Alendronate Sodium Tab 70Mg
BINOSTO is formulated with the same 70 mg of alendronate sodium as other standard alendronate weekly therapies, yet it is delivered in a tablet that dissolves in water.
BINOSTO offers the same 70 mg dose of alendronate sodium as other standard weekly therapies, but in a new formulation - a tablet that is dissolved in water to create an easy-to-swallow, strawberry-flavored liquid medication.
EX101 is a proprietary buffered effervescent dosage form of alendronate sodium administered once weekly for prevention and treatment of osteoporosis in postmenopausal women and incensement of bone mass in men with osteoporosis.
The empirical formula of alendronate sodium is C4H12NNaO7P2*3H2O and its formula weight is 325.
BINOSTO delivers the gold standard of alendronate sodium, the most broadly prescribed osteoporosis treatment for fracture prevention at the hip and spine, in a pleasant-tasting, once-weekly, buffered solution.
Alendronate sodium is chemically described as (4-amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt trihydrate.
BINOSTO delivers easy-to-swallow osteoporosis treatment and fracture prevention at the hip and spine -- alendronate sodium -- in a once weekly, buffered solution.
Utilizing EffRx's formulation technology, BINOSTO is the first and only buffered effervescent therapeutic to deliver the gold standard in osteoporosis treatment and fracture prevention of alendronate sodium in an easy-to-swallow, buffered solution.
PARIS -- Ipsen (ISIN:FR0010259150) (Paris:IPN) and MSD today announced the signing of a co-marketing agreement under which MSD will grant Ipsen the marketing rights in France for Adrovance(TM), a fixed combination of alendronate sodium and cholecalciferol (vitamin D3), indicated for the treatment of postmenopausal osteoporosis in patients at risk of vitamin D deficiency.